Family Medicine Education and CME

Select a Specialty

Clinical Insights in Pediatrics; Juvenile Idiopathic Arthritis: Diagnosis and Management in Primary Care
CMECE

Clinical Insights in Pediatrics; Juvenile Idiopathic Arthritis: Diagnosis and Management in Primary Care

Expiration Date: 9/14/2019
Credit Type(s): CME / NAPNAP CE / Participation | Credit: 0.75

Juvenile idiopathic arthritis (JIA) is the most common chronic inflammatory arthritis in the pediatric population, affecting over 300,000 children and adolescents in the…

go to activity»
Removing Barriers to PCSK9 Inhibitors

Removing Barriers to PCSK9 Inhibitors

This activity is sponsored by American Society for Preventive Cardiology.
Support for this program is provided by Amgen, Sanofi, and Regeneron.

August 24, 2018

In an effort to remove the obstacles standing between patients and access to PCSK9 inhibitors, the American Society for Preventive Cardiology (ASPC) held a series of…

go to activity»
J415
CME

Advanced Endoscopic Imaging: Recent Progress and Clinical Implications

This activity is supported by an educational grant from Fujifilm Medical Systems U.S.A., Inc.

Expiration Date: 8/23/2019
Credit Type(s): CME | Credit: 1

Gastrointestinal (GI) cancer is a leading cause of cancer-related deaths worldwide. To improve survival rates, the early detection and treatment of mucosal lesions is…

go to activity»
Therapeutic Drug Monitoring in Crohn’s Disease: Personalized Approaches for Treatment Optimization
CME

Therapeutic Drug Monitoring in Crohn’s Disease: Personalized Approaches for Treatment Optimization

This activity is supported by an educational grant from UCB, Inc.

Expiration Date: 7/15/2019
Credit Type(s): CME | Credit: 1.25

Despite the proven therapeutic efficacy of anti-tumor necrosis factor (TNF) agents, treatment failures due to primary nonresponse or secondary loss of response (LOR) can…

go to activity»
EGFR Mutated Lung Cancer Video Perspective

Edward S. Kim, MD, FACP, is chair of the department of solid tumor oncology at Levine Cancer Institute at Atrium Health in Charlotte, North Carolina. He spoke with…

go to activity»
CAD
CMECECPECNECDR

Management Implications of Non-HDL Lipids and Inflammation in CAD

This educational activity is supported by an educational grant from Amarin Pharma Inc.

Expiration Date: 6/26/2019
Credit Type(s): CME / CNE / CPE / CDR | Credit: 1

This 1-hour, highly interactive CME-certified symposium will feature a faculty of 5 leading international experts who will address the complex interrelationship of…

go to activity»
An oral test for adult growth hormone deficiency

Macrilen is the first and only FDA-approved oral test for diagnosing Adult Growth Hormone Deficiency….

go to activity»
Improving Access to PCSK9 Inhibitors: Issues and Recommendations

Improving Access to PCSK9 Inhibitors: Issues and Recommendations

This activity is sponsored by American Society for Preventive Cardiology.
Support for this program is provided by Amgen, Sanofi, and Regeneron.

August 24, 2018

In this collection of talks, panel discussions, and audience questions, Seth J. Baum, MD and colleagues illustrate the increasing difficulty clinicians and patients are…

go to activity»
The XIENCE Fluoroplymer

Due to thromboresistance and low inflammatory response, fluorinated surfaces encourage faster endothelization and healing. Learn how a Modern DES Fluoropolymer promotes…

go to activity»
Cardiology
CME

Strategies for Achieving LDL-C Goals to Reduce ASCVD Risk

This activity is supported by an educational grant from Amgen.

Expiration Date: 6/22/2019
Credit Type(s): CME | Credit: 0.5

There are numerous treatment options available for the management of familial hypercholesterolemia (FH) and non-familial hypercholesterolemia, but many patients remain…

go to activity»
NSCLC

Suresh S. Ramalingam, MD, deputy director of Winship Cancer Institute of Emory University, spoke with Healio about revolutionary treatment options, a possible predictive…

go to activity»
Game on!
CMECNECE

Test Your Confidence in the Use of PCSK9 Inhibitors – The Game On! Challenge

This activity is supported by an educational grant from Amgen.

Expiration Date: 6/24/2019
Credit Type(s): CME / CNE | Credit: 1.25

As clinical data emerge regarding the benefit of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors, obtaining access to these agents remains a barrier to…

go to activity»